Correlation Between ImmuCell and Candel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Candel Therapeutics, you can compare the effects of market volatilities on ImmuCell and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Candel Therapeutics.

Diversification Opportunities for ImmuCell and Candel Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between ImmuCell and Candel is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of ImmuCell i.e., ImmuCell and Candel Therapeutics go up and down completely randomly.

Pair Corralation between ImmuCell and Candel Therapeutics

Given the investment horizon of 90 days ImmuCell is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ImmuCell is 5.21 times less risky than Candel Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  209.00  in Candel Therapeutics on August 30, 2024 and sell it today you would earn a total of  286.00  from holding Candel Therapeutics or generate 136.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ImmuCell  vs.  Candel Therapeutics

 Performance 
       Timeline  
ImmuCell 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmuCell has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, ImmuCell is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Candel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

ImmuCell and Candel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ImmuCell and Candel Therapeutics

The main advantage of trading using opposite ImmuCell and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.
The idea behind ImmuCell and Candel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.